Medicine and Dentistry
Patient
100%
Infection
39%
Therapeutic Procedure
38%
Inpatient
36%
Hematologic Malignancy
35%
Acute Myeloid Leukemia
21%
Diagnosis
20%
Combination Therapy
20%
Mortality
19%
Systemic Mycosis
19%
COVID-19
17%
Mycosis
16%
Antifungal Agent
15%
Diseases
14%
Chemotherapy
12%
Antifungal Therapy
12%
Prophylaxis
11%
Invasive Aspergillosis
10%
Neoplasm
9%
Mortality Rate
9%
Adult
8%
Age
7%
Incidence
7%
Myelodysplastic Syndrome
7%
Neutropenia
7%
Drug
6%
Chemotherapeutic Agent
6%
Transplantation
6%
Stem Cell Transplant
6%
Mucormycosis
6%
Survival
6%
Allogeneic Hematopoietic Stem Cell Transplantation
6%
Posaconazole
5%
Bloodstream Infection
5%
Cohort Effect
5%
Voriconazole
5%
Amphotericin B
5%
Acute Leukemia
5%
Spontaneous Remission
5%
Leukemia
5%
Aspergillus
5%
Analysis
5%
Pathogen
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Azacitidine
5%
Hematology
5%
Infectious Complication
5%
Acute Lymphoblastic Leukemia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
28%
Infection
26%
Acute Myeloid Leukemia
18%
Systemic Mycosis
16%
Mycosis
14%
Mortality
12%
Posaconazole
12%
Amphotericin B
9%
Invasive Aspergillosis
9%
Diseases
9%
Chemotherapy
8%
Voriconazole
8%
Drug
7%
Antifungal
7%
Mortality Rate
6%
Myelodysplastic Syndrome
6%
Antifungal Agent
6%
Bloodstream Infection
6%
Infectious Complication
6%
Mould
5%
Neutropenia
5%
Immunology and Microbiology
Myeloid
6%
Mortality
5%